ACTIVE SESSION TAPE Biotechnology $3.09B Cap Quant: HOLD

Why Is Mineralys Therapeutics, Inc. (MLYS) Stock Down Today?

Updated Nov 22, 2026 11:08 AM ET ยท Prev Close $14.16

Pro Workspace
Last Session Price
$13.66 -3.53%
-$0.50 vs $14.16 prior close
Intraday Range
$13.57 โ€“ $14.79
Open $13.81
Relative Volume
0.70x Avg
1,345,245 sh
52-Week Range
$13.57 โ€“ $44.99
Benchmark Alpha
+0.11% vs SPY
+2.14% vs QQQ
20-Session Trend -33.6%

Session Regime & Catalyst Assessment

68% Signal Conviction
SECTOR 68% Driver Weight

Mineralys Therapeutics, Inc. Pulling Back 3.53% on 0.70x Relative Volume

Mineralys Therapeutics, Inc. (MLYS) is pulling back 3.53% (-$0.50) to $13.66 on 0.70x average session volume. Relative to benchmarks, MLYS is trading in line with the S&P 500 (+0.11% alpha). 14-day RSI stands at 28.7, keeping momentum in a oversold regime.

NEWS 70% Weight
Mineralys stock gains after drug shows sustained blood pressure cuts

Investing.com -- Mineralys Therapeutics Inc Nasdaq Mlys shares rose 4.7 in Monday trade after the company reported long-term results from its Transform-HTN trial showing lorundrostat demonstrated sustained blood pressure

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($13.66) trades relative to 20-day SMA ($16.53) and 50-day SMA ($21.12).

Volume Confirmation
LOW VOLUME (0.70x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

MLYS trading in line with the S&P 500 (+0.11% alpha)
MLYS Session
-3.53%
$13.66
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +0.11% Alpha vs QQQ: +2.14% Alpha vs XLV: -3.41%

Recent MLYS Catalyst Headlines

Verified Wire

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$12.91
Short-term support band
Upper Bound
$14.41
Short-term resistance band
Key Inflection Level
$13.57 (session support)

Monitor volume expansion above 1.5x RVOL around $13.57 (session support) for directional breakout confirmation.

Technical Regime (MLYS)

BEARISH MA TREND
RSI (14)
28.7
Oversold
20-Day SMA
$16.53
Below 20d
50-Day SMA
$21.12
Below 50d
MACD Signal
Bearish
MACD -2.05
ADX (14)
27.0
Strong trend
10d Momentum
-1.67
Soft 10-day momentum

Retail & Crowd Sentiment

Bullish
24h Messages
0
7d avg 0.6
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

StockTwits messages suggest bullish sentiment towards $MLYS, with mentions of Stifel's positive comments on Lorundrostat and potential M&A activity.

Reddit communities: 1 comment (Bullish)

About Mineralys Therapeutics, Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP โ€ฆ

Sector
Healthcare
Market Cap
$3.09B
Employees
51

Get Instant MLYS Catalyst Alerts

Receive an email alert when MLYS triggers an unusual volume breakout, options sweep, or rating shift.

MLYS Session & Catalyst FAQ

Why is MLYS stock down today?

Mineralys Therapeutics, Inc. (MLYS) is pulling back 3.53% (-$0.50) to $13.66 on 0.70x average session volume. Relative to benchmarks, MLYS is trading in line with the S&P 500 (+0.11% alpha). 14-day RSI stands at 28.7, keeping momentum in a oversold regime.

Is MLYS stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.70x relative volume (low participation). Our multi-factor model currently rates MLYS as HOLD. Review full valuation, quality, and timing signals on the MLYS Buy or Sell Decision Brief โ†’

What is MLYS's intrinsic value and expected trading range?

At $13.66, MLYS's modeled 1-to-3 session range is $12.91 โ€“ $14.41, with a key inflection level at $13.57 (session support). Compare current price against multi-year cash flow projections in the MLYS Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for MLYS?

RSI at 28.7 indicates oversold conditions โ€” watch for mean-reversion support. MLYS trades at $13.66 relative to its 20-day SMA ($16.53) and 50-day SMA ($21.12), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs